Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-11-09
2011-10-18
Allen, Marianne P (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S006800, C514S006900, C514S007200, C514S015200
Reexamination Certificate
active
08039432
ABSTRACT:
The present invention provides methods of administering an insulinotropic peptide in an amount effective to treat a disorder or condition while reducing nausea side effect by administering to a subject in need thereof an insulinotropic peptide conjugated to albumin. The present invention also provides methods of selecting a subject for administration of a conjugated insulinotropic peptide. Exemplary disorders or conditions treatable with an insulinotropic peptide include obesity and type II diabetes.
REFERENCES:
patent: 4206199 (1980-06-01), Fujino et al.
patent: 4251631 (1981-02-01), Simon
patent: 4423034 (1983-12-01), Nakagawa et al.
patent: 4462941 (1984-07-01), Lee et al.
patent: 4745100 (1988-05-01), Gilbard et al.
patent: 4766106 (1988-08-01), Katre et al.
patent: 4859604 (1989-08-01), Gould et al.
patent: 4902505 (1990-02-01), Pardridge et al.
patent: 5103233 (1992-04-01), Gallagher et al.
patent: 5118666 (1992-06-01), Habener
patent: 5120712 (1992-06-01), Habener
patent: 5424286 (1995-06-01), Eng
patent: 5493007 (1996-02-01), Burnier et al.
patent: 5545618 (1996-08-01), Buckley et al.
patent: 5574008 (1996-11-01), Johnson et al.
patent: 5580853 (1996-12-01), Sytkowski
patent: 5612034 (1997-03-01), Pouletty et al.
patent: 5612458 (1997-03-01), Hyldig-Nielsen et al.
patent: 5614487 (1997-03-01), Battersby et al.
patent: 5614492 (1997-03-01), Habener
patent: 5654276 (1997-08-01), Barrett et al.
patent: 5705483 (1998-01-01), Galloway et al.
patent: 5725804 (1998-03-01), Yen
patent: 5770570 (1998-06-01), Paul et al.
patent: 5807827 (1998-09-01), Lee et al.
patent: 5840733 (1998-11-01), Krantz et al.
patent: 5843440 (1998-12-01), Pouletty et al.
patent: 5846937 (1998-12-01), Drucker
patent: 5855866 (1999-01-01), Thorpe et al.
patent: 5869602 (1999-02-01), Jonassen et al.
patent: 5874408 (1999-02-01), Nayar
patent: 5939390 (1999-08-01), Flodgaard et al.
patent: 5942620 (1999-08-01), Krantz et al.
patent: 5958909 (1999-09-01), Habener
patent: 5981488 (1999-11-01), Hoffmann
patent: 6006753 (1999-12-01), Efendic
patent: 6087375 (2000-07-01), Bridon et al.
patent: 6103233 (2000-08-01), Pouletty et al.
patent: 6107489 (2000-08-01), Krantz et al.
patent: 6133235 (2000-10-01), Galloway et al.
patent: 6191102 (2001-02-01), DiMarchi et al.
patent: 6268343 (2001-07-01), Knudsen et al.
patent: 6277583 (2001-08-01), Krantz et al.
patent: 6277819 (2001-08-01), Efendic
patent: 6277863 (2001-08-01), Krantz et al.
patent: 6284725 (2001-09-01), Coolidge et al.
patent: 6329336 (2001-12-01), Bridon et al.
patent: 6358924 (2002-03-01), Hoffmann
patent: 6403324 (2002-06-01), Krantz et al.
patent: 6437092 (2002-08-01), Ezrin et al.
patent: 6440417 (2002-08-01), Thibaudeau et al.
patent: 6500918 (2002-12-01), Ezrin et al.
patent: 6506724 (2003-01-01), Hiles et al.
patent: 6514500 (2003-02-01), Bridon et al.
patent: 6528486 (2003-03-01), Larsen et al.
patent: 6583111 (2003-06-01), DiMarchi et al.
patent: 6593295 (2003-07-01), Bridon et al.
patent: 6602981 (2003-08-01), Ezrin et al.
patent: 6610825 (2003-08-01), Ezrin et al.
patent: 6660716 (2003-12-01), Yakubu-Madus et al.
patent: 6703359 (2004-03-01), Young et al.
patent: 6706689 (2004-03-01), Coolidge et al.
patent: 6706892 (2004-03-01), Ezrin et al.
patent: 6723530 (2004-04-01), Drucker
patent: 6767887 (2004-07-01), Hoffmann et al.
patent: 6821949 (2004-11-01), Bridon et al.
patent: 6849714 (2005-02-01), Bridon et al.
patent: 6858576 (2005-02-01), Young et al.
patent: 6861236 (2005-03-01), Moll et al.
patent: 6872700 (2005-03-01), Young et al.
patent: 6887470 (2005-05-01), Bridon et al.
patent: 6887849 (2005-05-01), Bridon et al.
patent: 6894024 (2005-05-01), Coolidge et al.
patent: 6902744 (2005-06-01), Kolterman et al.
patent: 6924264 (2005-08-01), Prickett et al.
patent: 6956026 (2005-10-01), Beeley et al.
patent: 6989366 (2006-01-01), Beeley et al.
patent: 6998387 (2006-02-01), Goke et al.
patent: 7090851 (2006-08-01), Bridon et al.
patent: 7101843 (2006-09-01), Glaesner et al.
patent: 7105508 (2006-09-01), Kling et al.
patent: 7112567 (2006-09-01), Bridon et al.
patent: 7144854 (2006-12-01), Bridon et al.
patent: 7166695 (2007-01-01), Krantz et al.
patent: 7259233 (2007-08-01), Dodd et al.
patent: 2001/0018421 (2001-08-01), Ezrin et al.
patent: 2001/0047084 (2001-11-01), Knudsen et al.
patent: 2002/0009441 (2002-01-01), Pouletty et al.
patent: 2002/0018751 (2002-02-01), Bridon et al.
patent: 2002/0039999 (2002-04-01), Ezrin et al.
patent: 2002/0049153 (2002-04-01), Bridon et al.
patent: 2003/0073630 (2003-04-01), Bridon et al.
patent: 2003/0108567 (2003-06-01), Bridon et al.
patent: 2003/0108568 (2003-06-01), Bridon et al.
patent: 2003/0170250 (2003-09-01), Ezrin et al.
patent: 2003/0232754 (2003-12-01), Holst et al.
patent: 2004/0053819 (2004-03-01), Dodd et al.
patent: 2004/0127398 (2004-07-01), Bridon et al.
patent: 2004/0138100 (2004-07-01), Bridon et al.
patent: 2004/0156859 (2004-08-01), Ezrin et al.
patent: 2004/0198654 (2004-10-01), Glaesner et al.
patent: 2004/0248782 (2004-12-01), Bridon et al.
patent: 2004/0266673 (2004-12-01), Bakis et al.
patent: 2005/0037974 (2005-02-01), Krantz et al.
patent: 2005/0065075 (2005-03-01), Erickson et al.
patent: 2005/0070475 (2005-03-01), Bridon et al.
patent: 2005/0176641 (2005-08-01), Bakis et al.
patent: 2005/0176643 (2005-08-01), Bridon et al.
patent: 2005/0187159 (2005-08-01), Bridon et al.
patent: 2005/0267293 (2005-12-01), Bousquet-Gagnon et al.
patent: 2006/0009377 (2006-01-01), Bridon et al.
patent: 2006/0058235 (2006-03-01), Bridon et al.
patent: 2006/0063699 (2006-03-01), Larsen
patent: 2006/0069029 (2006-03-01), Kolterman et al.
patent: 2006/0135426 (2006-06-01), Bridon et al.
patent: 2006/0135428 (2006-06-01), Bridon et al.
patent: 2006/0217304 (2006-09-01), Bridon et al.
patent: 2006/0233707 (2006-10-01), Kratz
patent: 2006/0252916 (2006-11-01), DiMarchi et al.
patent: 2009/0075890 (2009-03-01), Bridon et al.
patent: 2009/0093408 (2009-04-01), Bridon et al.
patent: 2501421 (2000-11-01), None
patent: 2434237 (2002-06-01), None
patent: 2550050 (2005-06-01), None
patent: 0602290 (1994-06-01), None
patent: 0969016 (2000-01-01), None
patent: WO 93/25579 (1993-12-01), None
patent: WO 96/06626 (1996-03-01), None
patent: WO 98/11126 (1998-03-01), None
patent: WO 99/24462 (1998-11-01), None
patent: WO 99/48536 (1999-09-01), None
patent: WO 00/69900 (2000-11-01), None
patent: WO 00/69902 (2000-11-01), None
patent: WO 00/70665 (2000-11-01), None
patent: WO 00/76550 (2000-12-01), None
Davies et al., Drugs of the Future, 30(6):553-557, Jun. 2005.
U.S. Appl. No. 09/623,533, filed Sep. 5, 2000, Bridon et al.
U.S. Appl. No. 09/623,543, filed Sep. 5, 2000, Bridon et al.
Adams et al., “Safety and Utilization of Blood Components as Therapeutic Delivery Systems,” Curr. Pharm. Biotechnol., 4(5):275-282 (2003).
Akil et al., “Endogenous Opioids: Biology and Function,” Ann. Rev. Neurosci., 7:223-255 (1984).
Baltzer et al., “The Addition of Ondansetron to the Combination of Metoclopramide, Dexamethasone, and Lorazepam Did Not Improve Vomiting Prevention in Patients Receiving High-Dose Cisplatin,” Cancer, 73:730-723 (1994).
Baggio et al., “A Recombinant Human Glucagon-Like Protein (GLP)-1 Albumin Protein (Albugon) Mimics Peptidergic Activation of GLP-1 Receptor-Dependent Pathways Coupled With Satiety, Gastrointestinal Motility and Glucose Homeostasis,” Diabetes, 53:2492-2500 (2004).
Barragan et al., “Interactions of exendin-(9-39) with the Effects of Glucagon-like Peptide-1-(7-36) Amide and of Exendin-4 on Arterial Blood Pressure and Heart Rate in Rats,” Regulatory Peptides, 67:63-68 (1996).
Bell et al., “Hamster Preproglucagon Contains the Sequence of Glucagon and Two Related Peptides,” Nature, 302:716-718 (1983).
Benhar et al., “Pseudomonas Exotoxin A Mutants,” J. Biol. Chem., 269(18):13398-13404 (1994).
Bennett et al., “An Antiemetic Study Comparing Halcion to Ativan in Children Receiving Cancer Chemotherapy,” Oncol. Nurs. Forum, 16(6):187A (1989).
Hirai et al., “A New Mast Cell Degranul
Bridon Dominique P.
Castaigne Jean-Paul
Thibaudeau Karen
Allen Marianne P
Conjuchem, LLC
Morrison & Foerster / LLP
LandOfFree
Method of treatment of diabetes and/or obesity with reduced... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment of diabetes and/or obesity with reduced..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of diabetes and/or obesity with reduced... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4282475